Exact Mass: 561.1781
Exact Mass Matches: 561.1781
Found 182 metabolites which its exact mass value is equals to given mass value 561.1781
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-Dealkylated derivative
5,9-Diepimer, N-Me,O3-de-Me,O3-beta-D-glucopyranoside-beta-Lumicolchicine
(7bS)-7c-(Acetyl-methyl-amino)-2-beta-D-glucopyranosyloxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]cyclbuta[1,2-c]cyclohepten-8-on|(7bS)-7c-(acetyl-methyl-amino)-2-beta-D-glucopyranosyloxy-1,3,9-trimethoxy-(7br,10ac)-6,7,7b,10a-tetrahydro-5H-benzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-8-one
His Tyr Gln Asp
Cys Asn Tyr Tyr
Cys Tyr Asn Tyr
Cys Tyr Tyr Asn
Asp His Gln Tyr
Asp His Tyr Gln
Asp Asn Gln Trp
Asp Asn Trp Gln
Asp Gln His Tyr
Asp Gln Asn Trp
Asp Gln Trp Asn
Asp Gln Tyr His
Asp Trp Asn Gln
Asp Trp Gln Asn
Asp Tyr His Gln
Asp Tyr Gln His
Glu His Asn Tyr
Glu His Tyr Asn
Glu Met Pro Trp
Glu Met Trp Pro
Glu Asn His Tyr
Glu Asn Asn Trp
Glu Asn Trp Asn
Glu Asn Tyr His
Glu Pro Met Trp
Glu Pro Trp Met
Glu Trp Met Pro
Glu Trp Asn Asn
Glu Trp Pro Met
Glu Tyr His Asn
Glu Tyr Asn His
His Asp Gln Tyr
His Asp Tyr Gln
His Glu Asn Tyr
His Glu Tyr Asn
His Asn Glu Tyr
His Asn Tyr Glu
His Gln Asp Tyr
His Gln Tyr Asp
His Tyr Asp Gln
His Tyr Glu Asn
His Tyr Asn Glu
Met Glu Pro Trp
Met Glu Trp Pro
Met Pro Glu Trp
Met Pro Trp Glu
Met Trp Glu Pro
Met Trp Pro Glu
Asn Cys Tyr Tyr
Asn Asp Gln Trp
Asn Asp Trp Gln
Asn Glu His Tyr
Asn Glu Asn Trp
Asn Glu Trp Asn
Asn Glu Tyr His
Asn His Glu Tyr
Asn His Tyr Glu
Asn Asn Glu Trp
Asn Asn Trp Glu
Asn Gln Asp Trp
Asn Gln Trp Asp
Asn Trp Asp Gln
Asn Trp Glu Asn
Asn Trp Asn Glu
Asn Trp Gln Asp
Asn Tyr Cys Tyr
Asn Tyr Glu His
Asn Tyr His Glu
Asn Tyr Tyr Cys
Pro Glu Met Trp
Pro Glu Trp Met
Pro Met Glu Trp
Pro Met Trp Glu
Pro Trp Glu Met
Pro Trp Met Glu
Gln Asp His Tyr
Gln Asp Asn Trp
Gln Asp Trp Asn
Gln Asp Tyr His
Gln His Asp Tyr
Gln His Tyr Asp
Gln Asn Asp Trp
Gln Asn Trp Asp
Gln Trp Asp Asn
Gln Trp Asn Asp
Gln Tyr Asp His
Gln Tyr His Asp
Trp Asp Asn Gln
Trp Asp Gln Asn
Trp Glu Met Pro
Trp Glu Asn Asn
Trp Glu Pro Met
Trp Met Glu Pro
Trp Met Pro Glu
Trp Asn Asp Gln
Trp Asn Glu Asn
Trp Asn Asn Glu
Trp Asn Gln Asp
Trp Pro Glu Met
Trp Pro Met Glu
Trp Gln Asp Asn
Trp Gln Asn Asp
Tyr Cys Asn Tyr
Tyr Cys Tyr Asn
Tyr Asp His Gln
Tyr Asp Gln His
Tyr Glu His Asn
Tyr Glu Asn His
Tyr His Asp Gln
Tyr His Glu Asn
Tyr His Asn Glu
Tyr His Gln Asp
Tyr Asn Cys Tyr
Tyr Asn Glu His
Tyr Asn His Glu
Tyr Asn Tyr Cys
Tyr Gln Asp His
Tyr Gln His Asp
Tyr Tyr Cys Asn
Tyr Tyr Asn Cys
ethyl 2-[1-[2-(1,3-benzodioxol-5-ylmethylamino)ethyl]-2-(2-imidazol-1-yl-6-methylpyrimidin-4-yl)pyrrolidin-3-yl]-1,3-thiazole-4-carboxylate
(2S,3R,4S,5R)-6-Chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3-pyrrolidine)-5-carboxamide
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor
N-(4-{[4-(diethylamino)phenyl](5-hydroxy-2,4-disulfophenyl)methylene}cyclohexa-2,5-dien-1-ylidene)-N-ethylethanaminium
N-[(4R,7R,8S)-5-(1,3-benzodioxole-5-carbonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4S,7R,8R)-5-[1,3-benzodioxol-5-yl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4S,7S,8S)-5-(1,3-benzodioxole-5-carbonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4R,7S,8S)-5-(1,3-benzodioxole-5-carbonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4R,7S,8R)-5-[1,3-benzodioxol-5-yl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4S,7S,8R)-5-[1,3-benzodioxol-5-yl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
N-[(4S,7R,8S)-5-[1,3-benzodioxol-5-yl(oxo)methyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3,3,3-trifluoropropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1-methyl-4-imidazolesulfonamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(2R,4aS,12aS)-5-methyl-6-oxo-8-(2,2,2-trifluoroethylsulfonylamino)-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(cyclohexylmethyl)acetamide
alpha-D-Kdo-4P-(2->6)-beta-D-GlcNAc-OAll
An amino disaccharide consisting of a 3-deoxy-4-O-phosphono-D-manno-oct-2-ulose residue attached to beta-glucosamine via an alpha-(2->6)-linkage with an O-allyl group at the anomeric centre.
alpha-D-Kdo-5P-(2->6)-beta-D-GlcNAc-OAll
An amino disaccharide consisting of a 3-deoxy-5-O-phosphono-D-manno-oct-2-ulose residue attached to beta-glucosamine via an alpha-(2->6)-linkage with an O-allyl group at the anomeric centre.
alpha-L-Fucp-(1->3)-[beta-D-Galp4Cl-(1->4)]-beta-D-GlcpNAc-OMe
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-3-(4-methoxyphenyl)-3-oxo-1-phenylpropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-aminoethyl beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(6,7-dimethoxy-2H-1,3-benzodioxol-5-yl)-1,3-dihydroxypropan-2-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid
Aerobactinate(3-)
A tricarboxylate arising from deprotonation of the three carboxylic acid groups of aerobactin; major species at pH 7.3.
Arg-Gly-Glu-Ser (TFA)
Arg-Gly-Glu-Ser TFA is a RGD-related peptide and a control for the RGDS ihibitory activity on fibrinogen binding to activated platelets.
MI-773
MI-773 is a potent MDM2-p53 protein‐protein interaction (PPI) inhibitor with high binding affinity against MDM2 (Kd=8.2 nM). MI-773 has antitumor activity[1][2].